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ABSTRACT. 
Modified thrombin-binding aptamers (TBAs) carrying uridine (U), 2’-deoxy-2’-
fluorouridine (FU) and North-methanocarbathymidine (NT) residues in the loop regions 
were synthesized and analyzed by UV thermal denaturation experiments and CD 
spectroscopy. The replacement of thymidines in the TGT loop by U and FU results in 
an increased stability of the antiparallel quadruplex structure described for the TBA 
while the presence of NT residues in the same positions destabilizes the antiparallel 
structure. The substitution of the thymidines in the TT loops for U, FU and NT induce a 
destabilization of the antiparallel quadruplex, indicating the crucial role of these 
positions. NMR studies on TBAs modified with uridines at the TGT loop also confirm 
the presence of the antiparallel quadruplex structure. Nevertheless, replacement of two 
Ts in the TT loops by uridine gives a more complex scenario in which the antiparallel 
quadruplex structure is present along with other partially unfolded species or 
aggregates. 
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1. Introduction 
Most cellular DNA in the cells occurs in the double helical form, built up from Watson-Crick 
base pairs. Nucleic acid sequences rich in guanines in particular are predisposed to form higher 
order structures because of the capacity of guanine bases to self associate via Hoogsteen 
hydrogen bonds to form planar tetrads. Several tetrads placed next to another stack in a very 
effective G-quadruplex structure1. Such structures are further stabilized by the presence of 
cations, especially potassium2. 
G-rich DNA or RNA sequences have been identified in biologically relevant regions of the 
genome3. These sequences are present in telomeres4 and in promoter regions of oncogenes such 
as c-myc5, c-Kit6, K-ras7 and others. 
Quadruplex structures differ in the number of associated strands and their orientation, and in 
the topology and conformation of the loops that connect the G-tetrads. When the guanine 
strands are oriented in opposite directions with loops above and below the terminal G-tetrad, the 
quadruplex is “antiparallel”. In this type of quadruplex, half of the guanines are oriented in syn 
around the glycosyl bond and the other half in anti8,9. In contrast, when all the guanines are 
oriented in the same direction with loops located on the side of the G-tetrads, the quadruplex is 
“parallel”. In this case, the glycosyl bonds of nucleosides adopt an anti-orientation8,10. Mixed 
parallel/antiparallel quadruplexes have also been observed11. Moreover intramolecular 
quadruplexes can exhibit several G-quadruplex conformations. For example, a number of 
studies have demonstrated that human telomere sequence forms various G-quadruplex 
structures12-15.  
While many of the studies have addressed modifications in the guanines of the G-tetrad and 
their implication in folding topology and molecularity16,17, less attention has been paid to the 
conformation of the nucleosides at the loop regions.  
Loops play a key role in determining the nature of the folding and stability of the G-
quadruplex18,19. Both loop length and sequence are crucial in the folding and can either stabilize 
or destabilize the quadruplex structure18. Loops are classified into the following groups, 
edgewise, diagonal, double-chain reversal and V-shaped20.  
Several authors have studied nucleotide substitution in quadruplex sequences containing a 
single base loop21 or different loop length compositions19,22,23. Recent studies involving 
quadruplexes with non-nucleosidic linkers instead of loops revealed the formation of parallel 
quadruplexes24. Another important point is the loop-loop interactions such as hydrogen bonding 
and stacking, which directly affect quadruplex topology25,26. In addition to these factors, cations 
also make a key contribution to the folding and stability of the quadruplex27,28. 
Although DNA G-quadruplex structure has been studied intensely, little is known about the 
stability and folding of RNA quadruplex sequences. These RNA quadruplexes are characterized 
by a parallel orientation of strands, which results from the preferential anti-orientation of their 
glycosyl bonds29. 
Vorlíčková et al. studied quadruplex formation by DNA/RNA hybrid analogues of G4T4G4, 
in particular the role of the dT4 loop and the effect of its substitution for rU430. Plavec’s group 
also studied the substitution of a T for U in the tetramolecular TG4T quadruplex, which has a 
parallel orientation of the four strands. This substitution favored the formation of dimeric 
structures d[(UG4T)4]2 in the presence of K+ and NH4+. In addition, Damha et al. examined the 
stabilization of 2’-deoxy-2’-fluoro-D-arabinonucleic acids (2’-F-ANA) on various positions 
including the loops of G-quadruplex structures31.   
Normally, the ring conformation or puckering can be conveniently described by two 
parameters, namely the pseudorotation angle and the amplitude of the puckering. In nucleosides 
and nucleotides structures, as well as in oligonucleotides, the sugar pseudorotation angle is 
populated essentially by two types of conformation, referred to as the North and South32,33. In 
the B-form of DNA, 2’-deoxyribose sugars exhibit a preferential 2’-endo/3’-exo (South) 
conformation, while A-form helices and RNA tend to have 2’-exo/3’-endo (North) puckering. 
Thrombin-binding aptamer (TBA) is a 15-mer DNA structure d(GGTTGGTGTGGTTGG) 
that specially binds to human thrombin34,35. NMR spectroscopy reveals that this structure adopts 
a uniquely folded structure with two stacked G-tetrads connected through edge-loops (one TGT 
and two TT loops) involving antiparallel alignment of the adjacent strands36-38. The TBA loops 
are crucial for the thrombin-binding and recognition. NMR shows that the two TT loops interact 
with the fibrinogen recognition site (exosite I) of one thrombin molecule and the TGT loop 
interacts with the heparin-binding site (exosite II) of a second thrombin molecule35. 
TBA is characterized by nucleotides with a South (S) sugar pucker. The loops of the aptamer 
adopt the anti orientation while the guanines on the same G-tetrad plane display alternating 
syn/anti conformations with respect to the glycosyl torsion angle36. The introduction of a 
nucleotide with opposite glycosyl orientation directly affects the stability of TBA16,17. Several 
authors have also studied the influence of the loop length and composition of the loops on the 
folding of the aptamer39. In addition, cation-binding to TBA is important for driving TBA 
stability40 and recently it has been described that a multiple pathway process is affected by the 
type of cation41. According to NMR experiments, TBA denaturation begins with the opening of 
the G-G base pairs that are not protected by a loop, followed by the opening the TGT loop42. 
Here we studied the conformational changes produced in TBA when the thymidines located 
in the loops are substituted by ribonucleosides (uridine and 2’-deoxy-2’-fluorouridine) or by the 
conformationally-restricted pseudonucleoside North-methanocarbathymidine43.  
2’-Fluoro-2’-deoxy ribonucleosides show a strong preference >90% for the North type 
conformer in solution37-39. North-methanocarbathymidine is a conformationally-restricted 
pseudonucleoside with a carbocyclic bicyclo[3.1.0]hexane ring. North or South-locked 
platforms can be prepared by shifting the position of the cyclopropane ring40,41.  
We found that the North conformation of these derivatives directly interferes with TBA 
folding and stability, thereby confirming the relevance of loop flexibility in TBA folding. 
 
2. Results and discussion 
2.1. Synthesis of modified thrombin-binding aptamer oligonucleotides  
Thymidines present in the loop regions of TBA were replaced by one or several uridine (U), 2’-deoxy-2’-
fluorouridine (FU) or North-methanocarbathymidine (NT) residues (Figure 1A). To this end, several 
oligonucleotide sequences were prepared by solid-phase phosphoramidite synthesis. U, FU and NT 
phosphoramidites were used for the synthesis of modified TBA sequences. The 2’-hydroxyl group of uridine 
was protected with the t-butyldimethylsilyl (TBDMS) group.  
First, the two thymidines located in the central loop of the aptamer formed by the T7G8T9 sequence were 
replaced by U (TBA-U7,U9), FU (TBA-FU7,FU9) or NT (TBA-NT7,NT9) (Figure 1B).  
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Figure 1. (A) North-Methanocarbathymidine, uridine and 2’-deoxy-2’-fluorouridine residues 
used for the synthesis of modified thrombin-binding aptamers (TBAs). (B) Scheme of the 
modified TBAs showing the changes in the TGT loop. (C) Scheme of the modified TBAs 
showing the changes in the TT loops. 
 
 
Two or four thymidines present in the two TT loops were then substituted by U, FU or NT. 
All four positions were modified by U, (TBA-U3,U4,U12,U13) or by FU (TBA-
FU3,FU4,FU12,FU13). Two U residues were introduced at different positions TBA-U3,U4 and 
TBA-U4,U13. The NT monomer was introduced in positions 4 and 13 (TBA-NT4,NT13) 
(Figure 1C).  
Oligonucleotide sequences were synthesized by standard protocols with an increasing 
coupling time for ribonucleotides and NT residues. After the assembly of the sequences, 
supports were treated with ammonia in order to remove the protecting groups and release the 
oligonucleotide from the support. In addition, the TBA sequences containing U were treated 
with fluoride solution to remove the TBDMS group. The DMT-on oligonucleotides were 
purified by HPLC. The modified aptamers were characterized by mass spectrometry (Table 1). 
 
Table 1. Mass spectra of modified thrombin-binding aptamers. 
 
Oligonucleotide Mass 
(found) 
Mass 
(expected) 
TBA-U7,U9 4727.7 4729.7 
TBA- FU7,FU9 4731.7 4733.7 
TBA-NT7,NT9 4743.9 4746.0 
TBA-U3,U4,U12,U13 4731.6 4733.7 
TBA-
FU3,FU4,FU12,FU13 
4739.8 4741.7 
TBA-U3,U4 4726.6 4729.7 
TBA-U4,U13 4726.9 4729.7 
TBA-NT4,NT13 4743.8 4746.0 
 
2.2. Thermal UV experiments   
Formation or dissociation of modified TBAs was estimated by heating/cooling experiments 
recording the UV absorbance as a function of temperature. This biophysical technique relies on 
the observation that the absorbance of guanines at 295 nm is higher in a G-quadruplex structure 
than in the denatured form. Here we determined the denaturation-renaturation profiles and the 
melting temperature of several modified aptamers at a range of concentrations 30, 15, 3 and 1.5 
µM (see supplementary data, table 1S). In most of the cases, the aptamers did not present 
hysteresis, thus the transitions were reversible and the melting and annealing curves were 
almost equivalent. The modified TBAs were classified into three groups on the basis of their 
melting profile (I, II, III, Table 2). The first category (I) included those with a similar stability to 
TBA and no melting dependence on the concentration. We interpreted this profile as a 
reversible G-quartet formation with relatively rapid kinetics. The second category (II) was 
characterized by a low reversible melting temperature that was affected by the concentration of 
the aptamer, thereby indicating a potential association of the strands. The third category (III) 
indicated a destabilized G-quadruplex structure as a result of a low melting temperature 
independent of the concentration. The midpoints of the melting transitions (Tm) and the 
difference with unmodified TBA were calculated for all oligonucleotides (Table 2). In 
particular, the central T7G8T9 loop modifications showed a distinct behaviour. The introduction 
of U7 and U9 and FU7 and FU were well tolerated in the TBA structure. TBA-U7,U9 had a 
higher melting temperature (54.8 ºC) while TBA-FU7,FU9 showed a small increase in melting 
temperature to TBA (51.9 ºC). No dependence of the melting temperature on the concentration 
was observed. Both aptamers were placed in group I with similar structural properties as 
unmodified TBA. 
At 3 μM TBA-NT7,NT9 had a low melting temperature 32.6 ºC. The melting profile was 
unusually high and broad at concentration of 30 µM, whereas at low concentration it was 
decreased. This TBA was classified in group II. As described in the CD section, this modified 
TBA partially lost the antiparallel structure. 
Derivatives with modifications in the T3,T4 and T12,T13 loops were the most sensitive to the 
position of the substitution and most of them were classified in group III. The stability of 
aptamers modified in the two TT loops was lower than unmodified TBA and structures with 
modifications with uridine or 2’-deoxy-2’-fluorouridine in the central T7G8T9 loop. The 
oligonucleotides with the four T positions modified by U (TBA-U3,U4,U12,U13) or by FU 
(TBA-FU3,FU4,FU12,FU13) showed melting temperatures of 32.2 and 42.8 ºC respectively. 
The melting temperatures of these two aptamers were independent of the aptamer concentration 
and these structures were classified in group III.  TBA-U3,U4,U12,U13 was observed to be a 
highly destabilized TBA derivative. Remarkably, TBA-FU3,FU4,FU12,FU13 had the highest 
melting temperature of this group and the melting/association processes differed slightly. In 
addition, at high concentration the melting temperature profile broadened. 
TBA-U4,U13 and TBA-NT7,NT9 displayed an important decrease in stabilitity with a 
melting temperature around 32 ºC. These oligonucleotides did not show hysteresis in the 
heating/cooling process. These two aptamers showed a similar profile with high and broad 
melting temperatures at concentrations of 15-30 µM. In contrast, at low concentrations the 
melting temperatures decreased. TBA-U4,U13 and TBA-NT7,NT9 were categorized in group 
II. 
Hydrogen bonding and base stacking interactions between T4 and T13 in the aptamer are 
essential for the aptamer stability, thus any modification in these positions directly affects TBA 
folding36,49.  
TBA-U3,U4 containing two continuous U residues showed a moderate decrease in the 
stability and the melting temperature was not affected by the concentration of the aptamer. This 
oligonucleotide was placed in the group III.   
 
Table 2.  UV denaturation data of modified thrombin-binding aptamersa  
 
Oligonucleotide Profile Tm 
(ºC) 
ΔTm 
(ºC) 
TBA I 49.9 -- 
TBA-U7,U9 I 54.8 +4.9 
TBA- FU7,FU9 I 51.9 +2 
TBA-NT7,NT9 II 32.6 -17.3 
TBA-
U3,U4,U12,U13 
III 32.2 -17.7 
TBA-
FU3,FU4,FU12,FU1
3 
III 42.8 -7.1 
TBA-U3,U4 III 41.0 -8.9 
TBA-U4,U13 II 32.2 -17.7 
TBA-NT4,NT13 III 31.0 -18.9 
a Uncertainty ± 0.5° C, ODN concentration: 3 µM. Buffer. 10 mM sodium cacodylate 100 
mM KCl pH 7 
 
To our knowledge, the analog FU has not been introduced into TBA to date. In contrast, 2’-
fluoroarabinothymidine (2’-F-araT) has been substituted in some TBA loop positions. This 
modified nucleoside has a DNA-like (South/East) conformation. The replacement of some loop 
thymidines caused a moderate increase in thermal stability with a concentration-independent 
melting profile and no hysteresis in the heating/cooling processes31.  
The introduction of FU in the TGT loop produced a moderate increase in TBA stability. In 
contrast, TBA-FU3,FU4, FU12,FU13 have the highest melting temperature of the aptamers 
modified in the TT loops. 
The NT substitution studied here is similar to LNA (Locked Nucleic Acid). LNA is also a 
bicyclo derivative with a 2’-O-4’-C-methylene-linked ribonucleoside. The sugar is also forced 
to be in the 3’-endo conformation and the conformational preference of the glycosyl bond is 
anti. LNA substitution in both loops decreased the stability of the TBA50. In particular, the 
replacement of the thymidines by the corresponding LNA derivative in position 4 resulted in the 
destabilization of the quadruplex. In the present study, the aptamers modified with North-
methanocarbathymidine had a low melting temperature; thus, this analogue produced a 
comparable destabilizing effect on aptamer stability. The restricted conformation of this analog 
may interfere with the quadruplex folding of the TBA aptamer. Although a recent study shows 
that North-methanocarbathymidine is flexible and it can also adopt a North /East (C4’-exo) 
conformation when present in a DNA loop.51  
The introduction of nucleoside derivatives that are flexible and have no sugar restrictions has 
been reported in various loop positions of TBA49,52. Generally, these derivatives are well 
tolerated. Nevertheless, Unlocked Nucleic Acids52 in positions 4, 9 or 13 of the TBA are less 
stable than the unmodified TBA. Surprisingly, the acyclic nucleoside N1-(3-hydroxy-2-
hydroxymethyl-2-methylpropyl)-thymine is tolerated and the stability of the loop-modified 
TBA was similar to unmodified TBA.  
Thermodynamic analysis of the UV melting curves53-55 for those sequences forming 
unimolecular antiparallel quadruplex (TBA, TBA-U7,U9, TBA-FU7,FU9) are presented in 
Table 3. Thermodynamic parameters for other modified TBAs were not calculated because the 
required two-state equilibrium is not clear for these compounds. 
 
Table 3.  Thermodynamic parameters of the thermal denaturation of unimolecular quadruplex 
 
Oligonucleotide 
ΔHº 
(Kcal/mol) 
ΔSº 
(cal/Kmol) 
ΔGº (25ºC) 
(Kcal/mol) 
TBA -45.53 ± 0.41 -140.94 ± 1.29 -3.50 
TBA-U7,U9 -47.51 ± 0.69 -144.84 ± 2.12 -4.32 
TBA-FU7,FU9 -44.19 ± 0.88 -135.94 ± 2.72 -3.66 
ODN concentration: 3 µM. Buffer. 10 mM sodium cacodylate 100 mM KCl pH 7 
 
TBA-U7,U9 appears to have a greater enthalpic contribution to the stability of their folded 
structure. The enthalpic differences between this aptamer and TBA and TBA-FU7,FU9 may be 
due to sugar pucker or other specific effects. TBA-U7, U9 is clearly more stable than TBA. On 
the other hand, TBA-FU7,FU9 is only slightly more stable than TBA.  
We then analyzed the thermal difference spectra (TDS) of the aptamers. The curves are the 
result of the arithmetic difference between high (80ºC) and low (15ºC) temperature absorbance 
spectra in the 230-340 nm wavelength range. The TDS of the modified aptamers matched the 
spectra of TBA, with two positive peaks at ~240 and ~275 nm and two negative peaks ~260 nm 
and ~295 nm. TBA-NT7,NT9 showed only one positive maxima ~275 nm and one negative 
peak ~295 nm (see supplementary data Figure 1S). 
2. 3 Circular Dichroism experiments 
Circular Dichroism (CD) spectra of all modified thrombin-binding aptamers were recorded 
(Figure 2). The CD spectra of these derivatives exhibited the characteristics described for the 
antiparallel quadruplex structure with two positive bands at ~245 and ~295 nm and a negative 
band at ~270 nm. This profile was similar to unmodified TBA but the magnitude of the band at 
~270 nm was less negative than the TBA at the same oligonucleotide concentration. 
Nevertheless, CD spectra of TBA-NT7,NT9 differed from the other modified thrombin-binding 
aptamers. The signature of this derivative contained two similar broad bands at ~255 nm and 
~290 nm which were shifted compared to an antiparallel quadruplex structure. This observation 
indicates partial loss of the antiparallel structure.  
2.4. NMR studies on modified thrombin-binding aptamer oligonucleotides 
TBA-U4,U13 and TBA-U7,U9 were selected for NMR studies as they are examples of a 
destabilizing or stabilizing uridine TBA modification, respectively, with respect to the 
unmodified TBA. 
2D NOESY experiments were performed on TBA-U4,U13 and TBA-U7,U9. Completed 
sequential assignments were obtained only for the latter following the known strategy for the 
quadruplex structure36,37. The proton chemical shifts for TBA-U7,U9 are reported in Table 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. CD spectra of the modified thrombin-binding aptamers (TBAs). A) TBAs modified in 
the central TGT loop. B) TBAs modified in the TT loops. 
 
Table 4.  
Proton chemical shift of TBA-U7,U9 in 10 mM potassium phosphate buffer and  5 mM KCl 
(pH 6.7), T=5°C 
 H8/H6 H1’ H2’ H2’’ H3’ Me6 /H5 NH 
G1 7.43 6.11 2.87 2.87 4.91 -- 12.10 
G2 8.21 6.11 3.04 2.35 5.15 -- 12.12 
T3 7.90 6.03 2.22 2.60 4.92 2.00 11.31 
T4 7.16 6.05 2.05 2.74 4.89 1.05 11.43 
G5 7.50 6.10 3.56 2.86 4.91 -- 12.31 
G6 7.72 6.05 2.93 2.59 5.18 -- 12.30 
U7 8.03 6.24 4.18 -- 4.55 6.03 11.31 
G8 7.50 5.73 1.98 2.31 4.89 -- 10.71 
U9 7.41 5.98 4.43 --- 4.43 5.98 10.40 
G10 7.43 6.07 3.72 2.99 4.92 -- 12.11 
G11 8.23 6.03 3.05 2.32 5.16 -- 12.11 
T12 7.91 6.19 2.23 2.67 4.92 2.00 11.43 
T13 7.17 6.09 2.07 2.61 4.95 0.98 11.43 
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G14 7.50 6.07 3.39 2.83 4.90 -- 12.30 
G15 8.10 6.15 2.70 2.44 4.81 -- 12.37 
 
The hydrogen-bonded imino protons gave rise to resonances in the 10.5–12.0 ppm range of the 
1D 1H NMR spectra of both aptamers. TBA-U7,U9 showed NMR features similar to 
unmodified TBA such as the number of signals, protons chemical shift and NOe patterns. 
Strong intraresidue NOe cross peaks between aromatic protons H6/H8 and anomeric protons 
H1’ were observed together with other non-sequential interactions. For example, H8, H1’, H2’ 
and H2” of G2 showed interactions with methyl, H2’ and H2” of T4. Moreover, aromatic and 
ribose protons of G11 showed an interaction with methyl and ribose protons of T13. Figure 3 
displays the H6/8-H1’ region of the NOESY spectra. In addition, the presence of eight sharp 
hydrogen-bonded G imino protons signals and four imino proton signals belonging to the 
oligonucleotide units of the loops indicated that a unique species with antiparallel structure was 
present in solution (Figure 4) as proved also by CD measurements.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Selected region of NOESY spectrum of TBA-U7,U9 acquired at 5°C 
 
For TBA-U7,U9 the increase in temperature from 5°C to  60°C resulted in a melting 
temperature of 56°C, as previously found with UV experiments, with the proton signals from 
10.5 to 11.5 ppm disappearing first.  The substitution of T4 and T13 by U4 and U13 affected the 
NMR spectra: the imino protons resonances between 10.5 and 12.5 ppm were broad and in 
superior number as will be expected for a unique species, thereby indicating that the chemical 
equilibria present in solution are complicated and that multiple species could be present in 
solution under the same experimental conditions at the ionic strength and temperature used for 
TBA-U7,U9. These resonances were temperature-sensitive and were fully exchanged at 35°C 
(Figure 4).  In order to better study the molecular species of the TBA analogues, we performed 
NMR DOSY experiments at room temperature. The diffusion coefficients (D) obtained were 10-
9,7979 m2s-1  for both aptamers.  This value corresponds to a molecular weight of a monomeric 
species. The NMR results for these two TBA derivatives were consistent with those from 
polyacrylamide gel electrophoresis (PAGE). TBA-U7,U9 and TBA appeared in the gel as a 
single spot whereas TBA-U4,U13 showed two or more spots indicating the formation of ditinct 
species (see supplementary material). 
 
3. Conclusions 
In summary, here we have studied the substitution of several thymidines located at the loop 
positions for derivatives with a North conformation (uridine, 2’-deoxy-2’-fluorouridine and 
North-methanocarbathymidine). Our findings demonstrate that changes in the conformation of 
the sugar puckering of the nucleotides present in loop regions are important for determining the 
folding and stability of TBA. 
The central TGT loop of TBA is more tolerant to modifications (except for NT) than the two 
lateral TT loops. The introduction of U and FU modifications into the TGT loop has a 
stabilizing effect on the antiparallel quadruplex structure of TBA. 
The thymidines located in the two TT loops are very sensitive to modification. This study and 
others demonstrate that the presence of thymidines in TT loops is essential to induce the folding 
of TBA into the antiparallel quadruplex. These thymidines cannot be replaced by 
ribonucleosides without a severe destabilization and this may explain why RNA quadruplex 
have a preference for parallel quadruplexes. Substitutions of positions 4 and 13 are crucial as 
there is a hydrogen bond between these two thymines that is critical for TBA folding37,38. The 
introduction of modifications in the two TT loops generates the formation of several species. 
Although it is difficult to assess the composition and structure of these species, data are 
provided to assign them to partially destabilized antiparallel structures or, in some cases, to 
dimers and other high-molecular aggregates, especially at high aptamer concentration. 
TBA loops are directly implicated in the interaction with and inhibition of thrombin. 
Normally, aptamers are DNA or RNA structures. Nevertheless, the synthesis of hybrid 
DNA/RNA TBAs could provide a new strategy to prepare aptamers with improved inhibitory 
properties. Research in these directions is currently underway and results will be presented in 
due course. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Imino regions of the NMR spectra of TBA-U7,U9 (left ) and of TBA-U4,U13 (right ) 
at a range of temperatures. 
 
4. Experimental Section 
4.1. Materials 
All the standard phosphoroamidites and reagents for DNA synthesis were purchased from 
Applied Biosystems and from Link Technologies. The remaining chemicals and solvents were 
from commercial sources (Sigma, Aldrich, Fluka) and were used without further purification. 
4.2. Oligonucleotide synthesis and purification 
The assembly of the modified TBAs was performed on a DNA/RNA synthesizer by solid-
phase 2-cyanoethylphosphoroamidite chemistry. Commercially available controlled pore glass 
functionalized with 5'-O-DMT-2'-deoxyguanosine was used as the solid support and tetrazole as 
the activator. Phosphoramidites of 2’-deoxynucleosides, 2’-O-TBDMS-protected uridine, and 
2’-F-uridine were obtained from commercial sources and the North-methanocarbathymidine 
monomer was obtained as described43. Coupling time was increased to 15 minutes for 
ribonucleotides and for North-methanocarbathymidine phosphoramidites. Oxidation using tert-
butyl hydroperoxide was used after the introduction of the North-methanocarbathymidine 
derivative43. The following oligonucleotides were synthesized in 0.2 µmol scale: TBA-
 
FU7,FU9, TBA-NT7,NT9, TBA-FU3,FU4, FU12,FU13, TBA-U3,U4, TBA-U3,U4,U12,U13, 
TBA-4U, and TBA-NT4,NT13. Oligonucleotides TBA-U7,U9 and TBA-U4,U13 were 
synthesized in 1 µmol scale. 
After synthesizing the aptamers using the DMT-on strategy, the solid supports were treated 
with an ammonia solution in order to cleavage the oligonucleotides from the solid support and 
remove the phosphate-protecting and base-protecting groups. In the next step, the 2’-O-
TBDMS-protecting group of oligonucleotides containing uridine derivatives was removed by 
treatment with a mixture of triethylamine hydrofluoride /triethylamine /1-methy-2-pyrrolidone 
(4:3:6). Fully deprotected oligonucleotides were purified by reverse phase semi-preparative 
HPLC in the DMT-on mode. Solvent A: 5% MeCN in 100 mM triethylammonium acetate (pH 
6.5) and solvent B: 70% MeCN in 100 mM triethylammonium acetate (pH 6.5). Column: 
Nucleosil 120C18 (10μm, 200 x 10mm). Flow rate: 3 ml/min. Conditions: 20 min linear gradient 
from 15-80% B. Finally, the DMT group was removed by a 30-minute treatment with 80% 
acetic acid. The aqueous phase was extracted with diethyl ether and the products were desalted 
on NAP-10 (Sephadex G-25) columns and characterized by mass spectrometry. 
Oligonucleotides used for NMR studies (TBA-U7,U9 and TBA-U4,U13)  were passed through 
a DOWEX (Na+) resin to exchange triethylammonium to sodium cations. The desired 
oligonucleotides were obtained in satisfactory overall yields (60-70 OD260 for 1 µmol and 15-20 
OD260 for 0.2 µmol). Oligonucleotides were characterized by mass spectrometry (MALDI-TOF, 
Table 1).  
4.3. UV Absorbance and Circular Dichroism measurements 
The thermal melting curves were obtained following the absorption change at 295 nm for 
TBA aptamers from 15°C to 80°C,  with a linear temperature ramp of 0.5°/min in Teflon-
stoppered 1-cm path-length quartz cells on a JASCO V-650 spectrophotometer equipped with a 
Peltier temperature control. For TBA derivatives all the measurements were repeated twice, 
conducted in 10 mM sodium cacodylate buffer, and 100 mM KCl (pH 7.0). Thermal melting 
curves of the aptamers were analyzed in a range of concentrations (1.5, 3, 15 and 30 µM). The 
denaturation-renaturation profiles (hysteresis) were studied at 3 µM. Samples were denatured at 
85ºC and left to slowly cool overnight prior to analysis. Melting curves of TBA, TBA, TBA-
U7,U9, TBA-FU7,FU9 were analyzed as described in the literature53-55 to extract 
thermodynamic parameters using Matlab program (R2009b version, Math-Works, Natick, MA, 
USA).  
The CD spectra were recorded on a JASCO spectropolarimeter J-810. CD spectra were 
registered between 220-320 nm. The samples (3 µM) were dissolved in 10 mM sodium 
cacodylate buffer, 100 mM KCl (pH 7.0) and annealed by heating to 85 ºC and slowly cooling 
to room temperature before recording spectra. 
4.4. NMR Spectroscopy 
The oligonucleotides were dissolved in 0.55 ml of H2O/D2O (90:10 v/v), corresponding to 0.8 
mM of quadruplex concentration, in the presence of 10 mM potassium phosphate buffer and 5 
mM KCl (pH 6.7).  
The NMR spectra were recorded on a Bruker AV600 spectrometer operating at a frequency 
of 600.10 MHz, for 1H nucleus. 1H spectra were recorded at variable temperature ranging from 
5 °C to 65°C. Chemical shifts (δ) were measured in ppm. 1H NMR spectra were referenced to 
external DSS (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt) set at 0.00 ppm.  Estimated 
accuracy for protons is within 0.02 ppm. 
Phase sensitive NOESY spectra were acquired in TPPI mode, with 4 K x 1024 complex 
FIDs, spectral width of 15.000 Hz, recycling delay of 1.5 s, and 96 scans. Mixing times ranged 
from 50 ms to 300 ms. TOCSY spectra were acquired with the use of an MLEV-17 spin-lock 
pulse (field strength 10.000 Hz, 60 ms total duration). All spectra were transformed and 
weighted with a 90° shifted sine-bell squared function to 4 K _ 4 K real data points. The 
sequential assignments of the modified TBAs were performed by applying well established 
procedures for the analysis of quadruplex DNA. The Sparky program was used to assign the 
NOESY cross-peaks 
Pseudo two-dimensional DOSY experiments56 were performed using the pulse-
program‘stebpgp1s’, diffusion delay: 0.12–0.40 s; gradient pulse: 1.5 ms; number of 
increments: 64. Raw data were processed using the standard DOSY software present in the 
Bruker library (TOPSPIN v. 1.3). A calibration curve was obtained using the following 
standards: glucose (MW 180; 3 mM in D2O 99.9%; NaCl 0.1 M, phosphate buffer 10 mM, pH 
6.7), d(CGTACG)2 (MW 3754; 3 mM in D2O 99.9%; NaCl 0.1 M, phosphate buffer 10 mM, 
pH6.7), aprotinin (MW 6500; 1 mM in D2O 99.9%; pH 6.8), lysozyme (MW 14400; 1 mM in 
D2O 99.9%; pH 6.9), trypsin (MW 23500; 1 mM in D2O 99.9%; pH 3.0) and LCTI (Lens 
culinaris trypsin inhibitor, MW 7447; 1 mM in D2O 99.9%; pH 3.0). 
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Table 1S. UV denaturation data of modified thrombin binding aptamers at different 
concentrations.a 
 
 TBA TBA-U7,U9 
TBA-
FU7,FU9 
TBA-
NT7,NT9 
TBA- 
U3,U4, 
U12,U13 
TBA-
FU3,FU4, 
FU12,FU13 
TBA-
U3,U4 
TBA-
U4,U13 
TBA-
NT4,NT13 
 
30µM 
 
50.3 57.2 52.3 52.9 35.6 43.2 42.0 39.8 34.8 
 
15µM 
 
51 57.0 53.0 33.8 37.2 42.4 41.4 38.2 33.8 
 
3 µM 
 
49.9 54.8 51.9 32.6 32.2 42.8 41.0 32.2 31.0 
 
1.5µM 
 
50.2 56.1 53.5 33.2 35.0 41.5 40.5 33.3 33.2 
 
a Buffer conditions:10mM sodium cacodylate 100 mM KCl pH 7 
 
 
 
Figure 1S.  Thermal Difference Spectra (TDS) of modified thrombin binding aptamer 
at 3 μM. A) TDS of aptamers modified in the T7G8T9 loop. B) TDS of aptamers 
modified in the T3,T4, T12,T13 loop positions. 
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Figure 2S. 15% Native polyacrylamide gel electrophoresis (PAGE) of modified 
thrombin-binding aptamers 
 
 
 
 
1. TBA                          5.  TBA-FU3,FU4, FU12,FU13     
2. TBA-NT7,NT9         6.  TBA 
3. TBA-U7,U9              7.  TBA-U4,U13 
4. TBA-FU7,FU9          8.  TBA-NT4,NT13 
           9.  TBA-U3,U4 
 
 
Modified aptamers (0.1 OD260 units) were dissolved in 40 mM Tris, 1 mM EDTA-
sodium, 20 mM AcOH, and 100 mM KCl (TAE-K). After the annealing, the samples 
were loaded on the native 15% polyacrylamide gel (acrylamide/bisacrylamide 19:1). 
The running buffer was TAE-K. The gel was kept at 4 ºC overnight at 60 mV in a SE-
600 Hoefer Scientific apparatus. After the electrophoresis, oligodeoxynucleotides were 
stained by STAINS-ALL (Sigma) using a solution of 20 mg of the dye in formamide 
(100 ml). The remaining blue stains were visualized and photographed.  
The TBA-U7,U9 aptamer and the TBA appeared in the gel as a single spot. The rest of 
the aptamers showed two o more spots indicating that the introduction of the 
modifications caused the formation of different species. Destabilized aptamers and the 
possibility of formation of aptamer aggregates may indicate different species with less 
mobility in the native gel. 
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